Michael Thomas Heffernan Insider Trading $ACTC Ocata Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Michael Thomas Heffernan.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Michael Thomas Heffernan. Michael Thomas Heffernan is Director in Ocata Therapeutics, Inc. ($ACTC).
Michael Thomas Heffernan in Ocata Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Michael Thomas Heffernan: Director
Holdings: 850,000 shares
Latest Transaction: Nov 18 2013
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Michael Thomas Heffernan in Ocata Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 18 2013 | ACTC | Ocata Therapeutics ... | Heffernan Michael Thomas | Director | Option Exercise | A | 0.06 | 125,000 | 7,500 | 125,000 | |
| Nov 18 2013 | ACTC | Ocata Therapeutics ... | Heffernan Michael Thomas | Director | Option Exercise | A | 0.06 | 125,000 | 7,500 | 125,000 | |
| Oct 02 2013 | ACTC | Ocata Therapeutics ... | Heffernan Michael Thomas | Director | Grant | A | 0.00 | 125,000 | 0 | 850,000 | 725 K to 850 K (+17.24 %) |
| Jul 01 2013 | ACTC | Ocata Therapeutics ... | Heffernan Michael Thomas | Director | Grant | A | 0.00 | 125,000 | 0 | 725,000 | 600 K to 725 K (+20.83 %) |
| Apr 01 2013 | ACTC | Ocata Therapeutics ... | Heffernan Michael Thomas | Director | Grant | A | 0.00 | 125,000 | 0 | 600,000 | 475 K to 600 K (+26.32 %) |
| Feb 26 2013 | ACTC | Ocata Therapeutics ... | Heffernan Michael Thomas | Director | Option Exercise | A | 0.06 | 500,000 | 28,950 | 500,000 | |
| Jan 04 2013 | ACTC | Ocata Therapeutics ... | Heffernan Michael Thomas | Director | Grant | A | 0.00 | 125,000 | 0 | 475,000 | 350 K to 475 K (+35.71 %) |
| Oct 03 2012 | ACTC | Ocata Therapeutics ... | Heffernan Michael Thomas | Director | Grant | A | 0.00 | 125,000 | 0 | 350,000 | 225 K to 350 K (+55.56 %) |
| Apr 18 2012 | ACTC | Ocata Therapeutics ... | Heffernan Michael Thomas | Director | Grant | A | 0.00 | 100,000 | 0 | 100,000 | 0 to 100 K |
Page: 1